ABPI response to appointment of new Patient Safety Commissioner

The Government has today announced the appointment of Dr Henrietta Hughes OBE as the first ever Patient Safety Commissioner for England.  

We look forward to working with Dr Hughes in her new role. Dr Amit Aggarwal, Medical Director, ABPI

In response, Dr Amit Aggarwal, Medical Director at the Association of the British Pharmaceutical Industry said: 

“Companies are committed to the highest standards of safety and efficacy in medicines and the voice of the patient should always drive improvement.

“The introduction of a Patient Safety Commissioner was an important recommendation made by Baroness Cumberlege in her First Do No Harm report. We look forward to working with Dr Hughes in her new role.”

TAGS
  • Safety

Related news

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.